American Vanguard Corporation
Key statistics
from XBRL data in SEC filingsAI briefing
from the latest 10-K, 10-Q and 8-K eventsAmerican Vanguard is a single-segment specialty and agricultural chemicals company that develops, manufactures and markets crop protection and nutrition, turf and ornamental, and commercial pest control products through its AMVAC subsidiaries.
What they do
AVD operates through AMVAC Chemical Corporation domestically and AMVAC Netherlands BV internationally, selling insecticides, fungicides, herbicides, soil health products, plant nutrition, molluscicides, growth regulators, soil fumigants and biorationals in liquid, powder and granular form. It synthesizes and formulates chemicals and ferments and extracts microbial products, and holds a position in closed delivery systems including SmartBox Plus, Lock n Load and EZ Load. The company reports one segment and sells primarily through purchase orders rather than a backlog.
Revenue drivers
- Domestic crop protection (AMVAC, OHP, GemChem, TyraTech) — U.S. product sales; domestic net sales were flat in 2025 while total net sales fell about 6%, making the U.S. the more stable part of the portfolio.
- International (AMVAC BV and subsidiaries) — Sales direct and through subsidiaries in Australia, Mexico, Brazil, Costa Rica, Ecuador and elsewhere; international net sales declined 14% in 2025.
- Granular soil insecticides in Mexico — Called out specifically as a source of weakness in 2025, significantly impacted by excessive channel inventory.
- Closed delivery systems (SmartBox Plus, Lock n Load, EZ Load) — The company states it has carved out a leadership position offering certain products in these proprietary application systems.
Recent performance
Annual revenue fell from $557.7M in 2021 to $515.1M in 2025, with net losses of $124.9M in 2024 and $49.9M in 2025. In the second quarter of 2026, net sales were $117 million versus $129 million a year earlier, gross margin was 30% versus 31%, and the company reported an operating loss of $0.30 million and a net loss of $9.9 million, or $0.34 per share. First-half 2026 net sales were $240 million versus $245 million, gross margin improved to 30% from 29%, and adjusted EBITDA rose to $16.9 million from $14 million. Operating cash flow was negative $21.2M in 2025, and the balance sheet at June 30, 2026 showed $635.3M in total assets, $454.0M in liabilities, $181.4M in equity and $265.4M of long-term debt.
Strategy
Management is executing a business improvement plan under the phrase 'Simplify, Prioritize and Deliver,' begun with outside consultants in 2024 and implemented by the current team in 2025. Actions include driving down supply chain and procurement costs, optimizing manufacturing, redefining the organizational structure, removing the AMVAC BV/AMVAC Hong Kong holding structure, rationalizing IT systems and relocating corporate headquarters. The L.A. plant optimization is expected to save at least $4 million annualized. First-half 2026 R&D investment rose 12% while operating expenses were reduced 3% year-over-year in the quarter.
Risks
- Agricultural cyclical downturn — Management states the agriculture economy is still in a cyclical downturn with commodity prices near historically low levels and uncertainty around inventory levels and crop acreage.
- International weakness — 2025 international net sales fell 14%, driven by prolonged severe drought in key Australian markets and excessive channel inventory for granular soil insecticides in Mexico.
- Customer destocking and deferred purchasing — Distributors, retailers and growers are described as ordering on an as-needed basis and deferring purchases month to month, shifting order patterns domestically and internationally.
- Leverage and weak cash generation — Long-term debt was $265.4M at June 30, 2026, and operating cash flow was negative $21.2M in 2025, with average indebtedness roughly flat at $194.7M.
Outlook
The company reaffirmed full-year 2026 guidance of adjusted EBITDA of $44 million to $48 million on sales of $530 million to $550 million. Management expects second-half cost benefits from the L.A. plant optimization and headquarters relocation, and says destocking has substantially run its course, though it does not expect a strong inventory rebuild. It characterizes the first half as steady progress on lowering costs and inventories and driving commercial improvement.